Evaluation of Circulating Neutrophils in Antisynthetase Syndrome
Recruiting
- Conditions
- Antisynthetase Syndrome
- Registration Number
- NCT05989399
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients with ASyS diagnosis according to Connors criteria<br><br>Exclusion Criteria:<br><br> - Active infection at ASyS diagnosis<br><br> - Evolutive cancer at ASyS diagnosis<br><br> - Corticosteroid therapy initiation before circulating neutrophils evaluation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method circulating neutrophils level > 7000/mm3;number of patients with global severity
- Secondary Outcome Measures
Name Time Method circulating neutrophils level;FVC;DLCO;grade of MRC muscle testing;CK level;circulating neutrophils level;BAL fluid neutrophils level